Answer
Phenytoin, a CYP3A inducer, may lower disopyramide blood levels and increase levels of its metabolite MN-disopyramide; this combination is not recommended because the magnitude of these effects is unpredictable.
Sources for this answer
- Rythmodan Retard 250mg Modified Release TabletsNeon Healthcare Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 2Document updated
Sources checked